Cooke Julie sold $2.2M of NBIX
Cooke Julie (Chief Human Resources Officer) sold 14,214 shares of NEUROCRINE BIOSCIENCES INC (NBIX) at $154.83 ($2.20M total) on 2026-06-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider-trading record but does not, by itself, change expected fundamentals or near-term catalysts.
Market read
Traders may briefly reassess sentiment around NBIX due to insider selling, but 10b5-1 typically limits interpretive impact.
What to watch
The filing date may lag the trade; without context on total insider activity and remaining holdings, the signal-to-noise is limited.
Background
SEC Form 4 reports an officer’s transaction in the issuer’s common stock; this one is explicitly under a pre-arranged Rule 10b5-1 plan.
Ticker impact
Neurocrine Biosciences insider disclosure shows CFO-level officer Julie Cooke sold 14,214 shares on 2026-06-02 under a 10b5-1 plan.
Low near-term impact; any reaction is likely muted unless accompanied by other company-specific news.
Form 4 provides transaction details but does not indicate new operational or regulatory developments; 10b5-1 reduces interpretive weight.
Market effects
Minimal; single-company insider sale without corroborating biotech catalyst is unlikely to reset sector expectations.
None.
None.
Counterpoint
Even with 10b5-1, clustered insider selling can coincide with private concerns; traders may still watch for follow-on disclosures.
Key entities
- issuerNeurocrine Biosciences, Inc.
Subject of the Form 4 insider transaction; officer Julie Cooke sold shares on 2026-06-02.
- insiderJulie Cooke
Chief Human Resources Officer who executed the open-market sale under a 10b5-1 plan.
